Personal protective equipment to protect against respiratory infections in healthcare settings in Pakistan
Citation: Chughtai AA, Khan W. Use of personal protective equipment to protect against respiratory infections in Pakistan: A systematic review. Journal of infection and public health. 2019;12(4):522-7
What is this? A variety of types of personal protective equipment (PPE) are being used to try to protect healthcare workers from infection with COVID-19. Policy makers in some countries, such as Pakistan, may find it useful to have a summary of the existing evidence specific to their country.
In this systematic review, the authors searched for research into the use of PPE for the prevention of respiratory infections in healthcare settings in Pakistan. They restricted their search to studies done in Pakistan and published in English up to December 2017. They included 13 observational or cross-sectional studies, which focused on influenza (2 studies), tuberculosis (2), or multiple respiratory diseases (including influenza) or general infections (9).
What was found: Guidelines and standard operating procedures for the use of PPE did not exist in most hospitals and laboratories in Pakistan, and recommendations for their use were inconsistent.
Face masks and gloves were the most commonly used PPE to protect from infections in healthcare settings in Pakistan.
PPE was not available in many healthcare facilities in Pakistan and its use was limited to high-risk situations.
Compliance with PPE use was low among healthcare workers in Pakistan, and there was some reuse of PPE.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.